182 related articles for article (PubMed ID: 14694668)
1. Missed opportunities in vaccination of patients with subsequent pneumococcal bacteraemia.
Weightman NC; Walters A
Br J Gen Pract; 2003 Jul; 53(492):547-9. PubMed ID: 14694668
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal bacteraemia and opportunities for prevention.
Drinkovic D; Wong CG; Taylor SL; Roberts SA; Morris AJ
N Z Med J; 2001 Jul; 114(1136):326-8. PubMed ID: 11548097
[TBL] [Abstract][Full Text] [Related]
3. Improving rates of pneumococcal vaccination on discharge from a tertiary center medical teaching unit: a prospective intervention.
Thomas CM; Loewen A; Coffin C; Campbell NR
BMC Public Health; 2005 Oct; 5():110. PubMed ID: 16225683
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
6. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
[TBL] [Abstract][Full Text] [Related]
7. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
Mangtani P; Roberts JA; Hall AJ; Cutts FT
Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
[TBL] [Abstract][Full Text] [Related]
8. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
10. [Pneumococcal bacteremia in Hvidovre Hospital 1986-1990].
Jensen C; Nielsen CM; Kolmos HJ
Ugeskr Laeger; 1993 Nov; 155(45):3665-70. PubMed ID: 8256359
[TBL] [Abstract][Full Text] [Related]
11. Implementation and evaluation of a nursing assessment/standing orders-based inpatient pneumococcal vaccination program.
Eckrode C; Church N; English WJ
Am J Infect Control; 2007 Oct; 35(8):508-15. PubMed ID: 17936141
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
[TBL] [Abstract][Full Text] [Related]
14. Invasive pneumococcal infection in first nations children in northern Alberta.
Vaudry W; Talling D
Can Commun Dis Rep; 2002 Oct; 28(20):165-72. PubMed ID: 12402519
[No Abstract] [Full Text] [Related]
15. Prophylaxis against pneumococcal infection after splenectomy: a challenge for hospitals and primary care.
Ejstrud P; Hansen JB; Andreasen DA
Eur J Surg; 1997 Oct; 163(10):733-8. PubMed ID: 9373223
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
Bergman A; Hjelmgren J; Ortqvist A; Wisløff T; Kristiansen IS; Högberg LD; Persson KM; Persson U
Scand J Infect Dis; 2008; 40(9):721-9. PubMed ID: 18712627
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
19. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience].
Konradsen HB; Henrichsen J
Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383
[TBL] [Abstract][Full Text] [Related]
20. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J
Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
